Literature DB >> 34581980

Overexpression of miR-149-5p Attenuates Cerebral Ischemia/Reperfusion (I/R) Injury by Targeting Notch2.

Xiaoya Wang1,2, Qingbao Xu3, Shali Wang4.   

Abstract

Ischemic stroke is one of the leading causes of death and disability worldwide. Although miR-149-5p downregulation is observed in rats after ischemia/reperfusion (I/R) injury, its function and role in ischemic stroke remain unclear. This study aimed to investigate the roles of miR-149-5p in I/R injury. The results showed that miR-149-5p was significantly downregulated in brain tissues of rats subjected to middle cerebral artery occlusion (MCAO) and primary cortical neurons subject to oxygen and glucose deprivation (OGD). MiR-149-5p overexpression effectively reduced MCAO/R-induced infarct volume, neurological score, and brain water content as well as OGD/R-induced cortical neurons apoptosis and OGD/R-induced expression of TNF-α, IL-4, IL-6, IL-1β, and COX-2. Moreover, Notch2 was identified as a target of miR-149-5p and Notch2 overexpression significantly attenuated the inhibitory effects of miR-149-5p mimics on inflammation and apoptosis. Taken together, our study revealed that miR-149-5p overexpression protects the rat brain against I/R injury by regulating Notch2-mediated inflammation and apoptosis pathway.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; I/R injury; Inflammation; Notch2; miR-149-5p

Mesh:

Substances:

Year:  2021        PMID: 34581980     DOI: 10.1007/s12017-021-08685-9

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   4.103


  41 in total

Review 1.  Canonical and non-canonical Notch ligands.

Authors:  Brendan D'Souza; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

2.  Overexpression of miR-224-3p alleviates apoptosis from cerebral ischemia reperfusion injury by targeting FIP200.

Authors:  Yiming Deng; Gaoting Ma; Qihao Dong; Xuan Sun; Lian Liu; Zhongrong Miao; Feng Gao
Journal:  J Cell Biochem       Date:  2019-05-27       Impact factor: 4.429

Review 3.  The many facets of Notch ligands.

Authors:  B D'Souza; A Miyamoto; G Weinmaster
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

Review 4.  Current advances in ischemic stroke research and therapies.

Authors:  Derek Barthels; Hiranmoy Das
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-15       Impact factor: 5.187

5.  MicroRNA-193b-3p alleviates focal cerebral ischemia and reperfusion-induced injury in rats by inhibiting 5-lipoxygenase expression.

Authors:  Zhihao Chen; Junqing Yang; Jianjun Zhong; Ying Luo; Weiming Du; Congli Hu; Hui Xia; Yuke Li; Jiahua Zhang; Miaomiao Li; Yang Yang; Haifeng Huang; Zhe Peng; Xiaodan Tan; Hong Wang
Journal:  Exp Neurol       Date:  2020-02-04       Impact factor: 5.330

Review 6.  Reactive astrocytes and therapeutic potential in focal ischemic stroke.

Authors:  Gourav Roy Choudhury; Shinghua Ding
Journal:  Neurobiol Dis       Date:  2015-05-14       Impact factor: 5.996

7.  MiR-485-5p Promotes Neuron Survival through Mediating Rac1/Notch2 Signaling Pathway after Cerebral Ischemia/Reperfusion.

Authors:  Xuan Chen; Sumei Zhang; Peipei Shi; Yangli Su; Dong Zhang; Na Li
Journal:  Curr Neurovasc Res       Date:  2020       Impact factor: 1.990

8.  Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells.

Authors:  Corinne Benakis; David Brea; Silvia Caballero; Giuseppe Faraco; Jamie Moore; Michelle Murphy; Giulia Sita; Gianfranco Racchumi; Lilan Ling; Eric G Pamer; Costantino Iadecola; Josef Anrather
Journal:  Nat Med       Date:  2016-03-28       Impact factor: 53.440

9.  Trends in the development of miRNA bioinformatics tools.

Authors:  Liang Chen; Liisa Heikkinen; Changliang Wang; Yang Yang; Huiyan Sun; Garry Wong
Journal:  Brief Bioinform       Date:  2019-09-27       Impact factor: 11.622

10.  Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro.

Authors:  Zhaohui Chai; Jiangbiao Gong; Peidong Zheng; Jiesheng Zheng
Journal:  Biol Res       Date:  2020-04-20       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.